These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 22185191

  • 1. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
    Barie PS, Hydo LJ, Shou J, Eachempati SR.
    Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
    [Abstract] [Full Text] [Related]

  • 2. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A, Iscra F, Di Capua G, Berlot G, Lucangelo U, Peratoner A, Fasiolo S, Viviani M, Consales C, Zicari A.
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [Abstract] [Full Text] [Related]

  • 3. Activated protein C in septic shock: a propensity-matched analysis.
    Sadaka F, O'Brien J, Migneron M, Stortz J, Vanston A, Taylor RW.
    Crit Care; 2011 Dec; 15(2):R89. PubMed ID: 21385410
    [Abstract] [Full Text] [Related]

  • 4. The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature.
    Funk DJ, Palma Vargas J, Tuttle-Newhall J, Moretti EW.
    Transpl Infect Dis; 2011 Dec; 13(6):592-7. PubMed ID: 21794040
    [Abstract] [Full Text] [Related]

  • 5. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E, Kumar A, Doucette S, Marshall J, Dial S, Gurka D, Dellinger RP, Sharma S, Penner C, Kramer A, Wood K, Ronald J, Kumar A, Turgeon AF, Houston DS, Zarychanski R, Co-operative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group.
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [Abstract] [Full Text] [Related]

  • 6. Factors influencing outcome of prolonged norepinephrine therapy for shock in critical surgical illness.
    Goncalves JA, Hydo LJ, Barie PS.
    Shock; 1998 Oct; 10(4):231-6. PubMed ID: 9788653
    [Abstract] [Full Text] [Related]

  • 7. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB, Corbett SW, Menes K, Cho T, Daugharthy J, Klein W, Wittlake WA.
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of activated protein C in real-life clinical practice.
    Dhainaut JF, Payet S, Vallet B, França LR, Annane D, Bollaert PE, Le Tulzo Y, Runge I, Malledant Y, Guidet B, Le Lay K, Launois R, PREMISS Study Group.
    Crit Care; 2007 Jan; 11(5):R99. PubMed ID: 17822547
    [Abstract] [Full Text] [Related]

  • 9. 90-day follow-up of patients treated with Drotrecogin Alfa (activated) for severe sepsis: a Belgian open label study.
    Decruyenaere J, De Backer D, Spapen H, Laterre PF, Raemaekers J, Rogiers P, Trine H, Sartral M, Haentjens T, Wagner T.
    Acta Clin Belg; 2009 Jan; 64(1):16-22. PubMed ID: 19317237
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of recombinant human activated protein C in patients with septic shock.
    Sanchez B, Piacentini E, Pradella V, Mignini M, Nava J.
    J Crit Care; 2010 Jun; 25(2):343-7. PubMed ID: 19781904
    [Abstract] [Full Text] [Related]

  • 11. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety.
    Laterre PF, Nelson DR, Macias W, Abraham E, Sashegyi A, Williams MD, Levy M, Levi M, Utterback B, Vincent JL.
    J Crit Care; 2007 Jun; 22(2):142-52. PubMed ID: 17548026
    [Abstract] [Full Text] [Related]

  • 12. Use of activated protein C in liver transplantation patients with septic shock.
    Rinaldi L, Marietta M, Mignini MA, Donno L, Busani S, Codeluppi M, Masetti M, Girardis M.
    Liver Transpl; 2008 Nov; 14(11):1598-602. PubMed ID: 18972572
    [Abstract] [Full Text] [Related]

  • 13. Drotrecogin alpha (activated) in neonatal septic shock.
    Frommhold D, Birle A, Linderkamp O, Zilow E, Pöschl J.
    Scand J Infect Dis; 2005 Nov; 37(4):306-8. PubMed ID: 15804668
    [Abstract] [Full Text] [Related]

  • 14. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort.
    Payen D, Sablotzki A, Barie PS, Ramsay G, Lowry S, Williams M, Sarwat S, Northrup J, Toland P, McL Booth FV.
    Surgery; 2006 Nov; 140(5):726-39. PubMed ID: 17084715
    [Abstract] [Full Text] [Related]

  • 15. Causes and consequences of fever complicating critical surgical illness.
    Barie PS, Hydo LJ, Eachempati SR.
    Surg Infect (Larchmt); 2004 Nov; 5(2):145-59. PubMed ID: 15353111
    [Abstract] [Full Text] [Related]

  • 16. Low-dose corticosteroid treatment in septic shock: a propensity-matching study.
    Funk D, Doucette S, Pisipati A, Dodek P, Marshall JC, Kumar A, Cooperative Antimicrobial Therapy of Septic Shock Database Research Group.
    Crit Care Med; 2014 Nov; 42(11):2333-41. PubMed ID: 25072758
    [Abstract] [Full Text] [Related]

  • 17. Decreasing magnitude of multiple organ dysfunction syndrome despite increasingly severe critical surgical illness: a 17-year longitudinal study.
    Barie PS, Hydo LJ, Shou J, Eachempati SR.
    J Trauma; 2008 Dec; 65(6):1227-35. PubMed ID: 19077606
    [Abstract] [Full Text] [Related]

  • 18. Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure.
    Brueckmann M, Wizenmann J, Hoffmann U, Seeger M, Bewig B.
    Thromb Res; 2003 Mar 15; 109(5-6):259-63. PubMed ID: 12818248
    [Abstract] [Full Text] [Related]

  • 19. [Focal surgery, antibiotic therapy--and then? The role of rhAPC in sepsis].
    Spies C, Otter H, Zuckermann-Becker H, Kox WJ.
    Kongressbd Dtsch Ges Chir Kongr; 2002 Mar 15; 119():834-43. PubMed ID: 12704933
    [Abstract] [Full Text] [Related]

  • 20. Use of drotrecogin alfa (activated) in two patients with severe sepsis.
    Mikaszewska-Sokolewicz M, Nierebińska M, Mayzner-Zawadzka E.
    Med Sci Monit; 2003 Aug 15; 9(8):CS80-7. PubMed ID: 12942037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.